Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview
Fentanyl citrate remains among the most vital tools in modern-day anaesthesia and acute pain management throughout the United Kingdom. As a potent artificial opioid, its role in the National Health Service (NHS) and private surgical sectors is reputable, mainly due to its fast beginning of action and cardiovascular stability. Fentanyl Citrate Injection Brand Names UK offers a thorough introduction of fentanyl citrate injection solutions available in the UK, their scientific signs, regulative landscape, and administration procedures.
What is Fentanyl Citrate?
Fentanyl citrate is a potent phenylpiperidine-derivative opioid agonist. It was very first manufactured in 1960 and rapidly became a foundation of perioperative care. In regards to effectiveness, fentanyl is approximately 50 to 100 times more powerful than morphine. Its high lipophilicity enables it to cross the blood-brain barrier quickly, leading to a practically immediate analgesic impact when administered intravenously.
In the UK, fentanyl citrate is mainly used through the parenteral path (injection) for both sedative and analgesic functions. It works mainly by binding to the mu-opioid receptors in the central nerve system, altering the understanding of discomfort and the emotional reaction to it.
Clinical Indications in the UK
According to the British National Formulary (BNF), fentanyl citrate injection is indicated for numerous specific scientific circumstances:
- Analgesic Action: Used during brief personnel treatments and in the recovery room.
- Analgesic Supplement: Used throughout the induction and maintenance of inhalation anaesthesia.
- Neuroleptanalgesia: Often used in mix with a neuroleptic (such as droperidol) to achieve a state of quiescence and minimized awareness.
- Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for clients on mechanical ventilation.
- Pre-medication: To offer sedation and analgesia before the induction of basic anaesthesia.
Offered Formulations and Strengths in the UK
The UK market uses several formulas of fentanyl citrate, designed to satisfy the differing requirements of surgical and emergency situation departments. These are typically presented as clear, colourless services for injection or infusion.
Table 1: Common Fentanyl Citrate Formulations in the UK
| Strength (Fentanyl base) | Presentation | Common Packaging | Manufacturer Examples |
|---|---|---|---|
| 50 micrograms/ml | 2 ml Ampoule | Pack of 10 | Hameln, Advanz Pharma |
| 50 micrograms/ml | 10 ml Ampoule | Load of 5 or 10 | Hameln, Wockhardt |
| 50 micrograms/ml | 20 ml Vial/Ampoule | Pack of 5 | Hameln, Generic |
| 50 micrograms/ml | 50 ml Vial | Individual/Pack of 1 | Generic (ICU usage) |
Note: While 50 mcg/ml is the basic concentration, specialised formulations for epidural or intrathecal use may in some cases be prepared by medical facility pharmacies under particular protocols.
Pharmacokinetics and Pharmacodynamics
Comprehending how the body processes fentanyl is vital for safe administration.
- Onset of Action: When administered intravenously, the effect begins almost right away, though the maximal analgesic effect might take 3 to 5 minutes.
- Duration: A single intravenous dosage of 100 micrograms typically lasts for 30 to 60 minutes.
- Metabolism: Fentanyl is mostly metabolised in the liver via the CYP3A4 enzyme system.
- Excretion: Approximately 75% of the dosage is excreted in the urine within 24 hours, mostly as metabolites.
Administration Protocols
In the UK, the administration of fentanyl citrate is strictly controlled and generally carried out by anaesthetists or trained specialists in controlled environments.
Dosage Guidelines
Dose must be horizontal and individualised based upon the client's age, weight, physical status, underlying pathological condition, usage of other drugs, and the type of surgery.
- Low Dose (2 mcg/kg): Useful for minor surgeries.
- Moderate Dose (2-- 20 mcg/kg): Used when surgery is more intrusive; requires respiratory monitoring.
- High Dose (20-- 50 mcg/kg): Used during "trouble-free" significant surgical treatments (e.g., open-heart surgical treatment) to safeguard the myocardium from the metabolic needs of tension.
Paths of Administration
- Intravenous (IV) Bolus: Common for induction.
- Intravenous Infusion: Used for longer procedures or in the ICU.
- Intramuscular (IM): Less typical, however utilized for pre-medication in particular scenarios.
Regulatory Status and Safety
In the United Kingdom, Fentanyl is classified under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is classified as a Schedule 2 Controlled Drug (CD POM).
Statutory Requirements for UK Hospitals:
- Safe Custody: Must be saved in a locked managed drug cupboard.
- Record Keeping: Every administration should be tape-recorded in a Controlled Drugs Register (CDR).
- Damage: Surplus or ended fentanyl should be denatured and experienced by authorised workers.
Negative Effects and Adverse Reactions
While highly efficient, fentanyl citrate brings a threat of considerable side results.
- Respiratory Depression: The most serious side result, which can lead to breathing arrest if not kept an eye on.
- Bradychardia: Often managed with atropine.
- Muscle Rigidity (Chest Wall Rigidity): High dosages can make ventilation tough, requiring using neuromuscular obstructing representatives.
- Queasiness and Vomiting: Common in the postoperative period.
- Hypotension: Although more stable than morphine, it can still occur, specifically in hypovolaemic patients.
Comparison with Other Opioids
Clinicians frequently pick fentanyl over other opioids due to its specific pharmacokinetic profile.
Table 2: Comparison of Parenteral Opioids in UK Practice
| Function | Fentanyl | Morphine | Remifentanil |
|---|---|---|---|
| Relative Potency | 100 | 1 | 100-200 |
| Start | 1-- 3 minutes | 15-- 30 minutes | 1 minute |
| Duration of Action | 30-- 60 minutes | 3-- 4 hours | 5-- 10 minutes |
| Histamine Release | Minimal | Significant | Minimal |
| Primary Use | Intraoperative/ICU | Post-operative/Chronic | Titratable Infusion |
Often Asked Questions (FAQ)
1. Is fentanyl citrate injection the same as the fentanyl patches?
No. While they contain the exact same active drug, the injection is for instant, acute use in surgical or emergency situation settings. Patches (transdermal delivery) are developed for chronic, long-term discomfort management and release the medication slowly over 72 hours.
2. Can fentanyl citrate be utilized for children in the UK?
Yes, it is regularly used in paediatric anaesthesia. However, the dosage must be strictly calculated based upon the kid's weight, and they need to be kept an eye on carefully for respiratory anxiety.
3. What is the antagonist for fentanyl?
Naloxone is the specific medicinal antagonist utilized to reverse the results of fentanyl, consisting of respiratory depression. In UK hospitals, naloxone needs to constantly be readily offered any place fentanyl is administered.
4. Why is it utilized over morphine in heart surgical treatment?
Fentanyl is preferred in heart surgery because it does not cause the release of histamine, which can lead to vasodilation and hypotension. It supplies cardiovascular stability even at high doses.
5. What are the storage requirements?
Fentanyl citrate injection should be kept below 25 ° C and secured from light. As a Schedule 2 drug, it must be kept in a legally compliant CD cupboard.
Fentanyl citrate injection formulations are indispensable parts of the UK's medical toolkit for managing perioperative discomfort and assisting in complex surgeries. Its high potency and quick onset offer unrivaled precision for anaesthetists, supplied that strenuous monitoring and regulatory standards are kept. By comprehending the different concentrations and the strict protocols surrounding its use, healthcare professionals guarantee that this powerful medication remains both safe and reliable for patients throughout the country.
Disclaimer: This post is for educational purposes just and does not make up medical guidance. Healthcare professionals must constantly refer to the Summary of Product Characteristics (SmPC) and present BNF standards for the most up-to-date recommending details.
